Max Fiebiger

A scientist specializing in immunology and molecular biology, Max got his PhD from Ludwig-Maximilians University in Munich and continued his training as a postdoctoral fellow at Rockefeller University.

He has over 10 years of experience in molecular immunology and cell biology, interfacing between academia and industry, and prior experience developing antibody-based therapeutics.

Most recently he worked at Siolta Therapeutics, where he helped build out the R&D programs and led the immunology and translational research groups.

Max joined Sonoma Biotherapeutics in early 2020 as a Scientist where he is leading the in vivo modeling team.